Ibandronic acid
Ibandronic acid is a highly effective nitrogen-containing bisphosphonate that can be used for osteoporosis.
Product Specifications
CAS Number
114084-78-5
UNSPSC
12352211
Hazard Statement
H302-H315-H319-H335
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Ibandronic-acid.html
Solubility
10 mM in DMSO
Smiles
OC(P(O)(O)=O)(P(O)(O)=O)CCN(C)CCCCC
Molecular Formula
C9H23NO7P2
Molecular Weight
319.23
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78 (3) : p. 453-8.|[2]Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50 (1) : p. 127-33.|[3]Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19 (8) : p. 1241-9.|[4]Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29 (10) : p. 2200-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC205827L3V 200 µL
ZC3H15 (NM_018471) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 